Seres Therapeutics Inc buy Quitte
Start price
17.08.16
/
50%
€10.03
Target price
17.02.17
€12.80
Performance (%)
-10.50%
End price
17.02.17
€8.97
Summary
This prediction ended on 17.02.17 with a price of €8.97. The prediction for Seres Therapeutics Inc disappointed with a performance of -10.50%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seres Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -2.486% | 0.323% | 0.748% | 51.017% |
| iShares Nasdaq 100 | -4.401% | 1.587% | 32.085% | 87.968% |
| iShares Nikkei 225® | -4.295% | 0.970% | 50.000% | 61.272% |
| iShares S&P 500 | -2.199% | 2.005% | 22.599% | 65.117% |
Comments by Quitte for this prediction
In the thread Seres Therapeutics Inc diskutieren
hübsches Cash-Polster
und eine üble Abstrafung lassen mich hier zuversichtlich sein
(Laufzeit überschritten)

